Spotlight January 2022: Methods, models, mechanisms and metadata

Home > Spotlight January 2022: Methods, models, mechanisms and metadata

For the new year, we are presenting no “classic” paper here, but would like to point out an editorial: Methods, Models, Mechanisms and Metadata: Introduction to the Nanotoxicology Collection at F1000 Research.

This editorial introduces the F1000Research Nanotoxicology Collection, where best practices can be collected in the form of original research reports, including no-effect studies, protocols and methods papers, software reports and systematic reviews. The aim of the collection is to provide an open access platform for nanotoxicology researchers to support an improved culture of data sharing and documentation of evolving protocols, biological and computational models, software tools and datasets that can be used and built upon to develop predictive models and in-silico nanotoxicology and nanoinformatics.

F1000Research (https://f1000research.com/) is an open-research publishing platform for scientists, academics and clinicians, enabling rapid publication of articles and other research outputs without editorial interference. All articles benefit from transparent peer review and editorial guidance to make all source data openly available.

 

Original publication:

Lynch I, Nymark P, Doganis P et al. Methods, models, mechanisms and metadata: Introducing the Nanotoxicology collection at F1000Research [version 1; peer review: not peer reviewed] F1000Research 2021, 10:1196 https://doi.org/10.12688/f1000research.75113.1

 

Spotlight January 2022: Methods, models, mechanisms and metadata

Weitere Spotlights


Spotlight September: A methodology for the automatic evaluation of data quality and completeness of nanomaterials for risk assessment purposes

Spotlight September: A methodology for the automatic evaluation of data quality and completeness of nanomaterials for risk assessment purposes

This paper describes a method for automatically assessing the quality and completeness of nanosafety data for the purpose of risk assessment. Steps to develop the methodology for assessing data completeness and the methodology for assessing quality are presented. The methodology is tailored to physicochemical and hazard (meta) data, but can also be configured with appropriate […]

Read more

Spotlight October 2020: Nanosafety – Topic of the Future

Spotlight October 2020: Nanosafety – Topic of the Future

Research on nanosafety is a driver of innovation as the spotlight in July has demonstrated. But furthermore, this research field is built on routine as well if researchers look for the “needle in the haystack”. In many areas the safety research initiates the development of new methods, e.g. for the determination of nanoparticles within exposed organisms via […]

Read more

Spotlight August 2023: From principles to reality. FAIR implementation in the nanosafety community

Spotlight August 2023: From principles to reality. FAIR implementation in the nanosafety community

In the August 2023 Spotlight, we present a paper that addresses the implementation of FAIR (Findability, Accessibility, Interoperability and Reusability) Data in nanosafety research. The authors introduce the new AdvancedNano GO FAIR Implementation Network (see also https://www.go-fair.org/implementation-networks/overview/advancednano/) established as part of the GO FAIR initiative. The paper highlights the AdvancedNano GO FAIR Implementation Network’s support […]

Read more

Spotlight October 2022: The titanium dioxide debate – why the current ECHA and EFSA hazard classification should be questioned

Spotlight October 2022: The titanium dioxide debate – why the current ECHA and EFSA hazard classification should be questioned

Due to various reports and scientific studies, titanium dioxide (TiO2)was also banned in Europe this year (2022) for use as a food additive with the indication that it could possibly be carcinogenic to humans. Although no case of tumour induction in humans has been reported since the use of this material in micro but also […]

Read more

Skip to content